Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Hajar Alqahtani"'
Autor:
Ahlam Alghamdi, Hajar AlQahtani, Sara Albilal, Maram Mater Almutairi, Nouf Alobaidallah, Linah Alghamdi, Amal Alfayez, Thamer Almangour, Ahmed Al-jedai
Publikováno v:
Annals of Saudi Medicine, Vol 43, Iss 6, Pp 373-379 (2023)
BACKGROUND: Infection is the second-leading cause of death among cancer patients, but there have been few studies on the effectiveness of novel antimicrobial agents to treat carbapenem-resistant Enterobacterales in cancer patients. OBJECTIVE: Evaluat
Externí odkaz:
https://doaj.org/article/01646eb786d94459a20632a4dc9bcf40
Autor:
Hajar AlQahtani, Sara AlBilal, Ebrahim Mahmoud, Omar Aldibasi, Ahmad Alharbi, Nour Shamas, Abdulrahman Alsaedy, Kenana Owaidah, Fulwah Yahya Alqahtani, Fadilah Sfouq Aleanizy, Hatim Arishi, Saleem Baharoon, Mohammad Bosaeed
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 1, Pp 36-41 (2022)
Introduction: Immunomodulators, including dexamethasone (DEX), have been recommended by the Infectious Disease Society of America (IDSA) to treat moderate, severe, and critical COVID-19. Tocilizumab (TCZ) was added to the treatment recommendations ba
Externí odkaz:
https://doaj.org/article/192cbf0901c64e21ab23483d30a99fba
Autor:
Fadilah S. Aleanizy, Fulwah Y. Alqahtani, Marzouqah S. Alanazi, Rania A.E.H. Mohamed, Bahauddeen M. Alrfaei, Mana M. Alshehri, Hajar AlQahtani, Ghalia Shamlan, Nassr Al-Maflehi, Maha M. Alrasheed, Ahmed Alrashed
Publikováno v:
Journal of Infection and Public Health, Vol 14, Iss 9, Pp 1133-1138 (2021)
Background: COVID-19 is newly emerging infectious disease that spread globally at unpredictable and unique pattern to the extent that the World Health Organization announced COVID-19 as a pandemic in the first couple months of 2020. This study aims t
Externí odkaz:
https://doaj.org/article/bbc74da4550a4e55a49e281d3119cb8e
Autor:
Ebrahim Mahmoud, Reem Abanamy, Eman Binawad, Hind Alhatmi, Ali Alzammam, Abdulrahman Habib, Dana Alturaifi, Ahmed Alharbi, Hajar Alqahtani, Mohammed Aldohayan
Publikováno v:
Journal of Infection and Public Health, Vol 14, Iss 7, Pp 839-844 (2021)
Purpose: Little is known regarding the burden of infections and clinical practice towards hospitalized patients with limits on life-sustaining measures. We aim to describe the infectious syndromes, clinical care, the emergence of multi-drug resistant
Externí odkaz:
https://doaj.org/article/9315f5b045364822af6b132c4cdaaa1c
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 24, Iss , Pp 23-26 (2021)
Objectives: Recent studies have shown that methicillin-resistantStaphylococcus aureus (MRSA) bacteraemia with vancomycin minimum inhibitory concentration (MIC) >1 μg/mL is associated with a higher rate of treatment failure and a higher mortality rat
Externí odkaz:
https://doaj.org/article/acc498b6e9664c81b72ddc14ce63b1f1
Autor:
Fadilah Sfouq Aleanizy, Fulwah Yahya Alqahtani, Jouri Alanazi, Hajar AlQahtani, Marzouqah Alanazi
Publikováno v:
Journal of Nature and Science of Medicine, Vol 3, Iss 4, Pp 362-365 (2020)
Objective: Coronavirus disease 2019 (COVID-19) has emerged in China at the end of the year 2019 and a few weeks later it has out broken globally. There are obvious geographical variations in the mortality rates of COVID-19 according to the data publi
Externí odkaz:
https://doaj.org/article/975aa93c434841289281ec107b3a9c35
Autor:
Menyfah Q. Alanazi, Hajar AlQahtani, Thamer A. Almangour, Fadilah Sfouq Aleanizy, Fulwah Yahya Alqahtani
Publikováno v:
Antibiotics, Vol 11, Iss 11, p 1478 (2022)
This study aims to assess the prevalence and antibiotic-treatment patterns of respiratory tract infections (RTIs), prevalence and types of antibiotic-prescribing errors, and the cost of inappropriate antibiotic use among emergency department (ED) pat
Externí odkaz:
https://doaj.org/article/4191668b5ae94eb5961294b6844ae11e
Autor:
Mohammad Bosaeed, Ebrahim Mahmoud, Mohammad Hussein, Ahmad Alharbi, Abdulrahman Alsaedy, Adel Alothman, Majed Aljeraisy, Hajar Alqahtani, Marwan Nashabat, Badriah Almutairi, Manar Almaghaslah, Omar Aldibasi, Sameera AlJohani, Abderrezak Bouchama, Yaseen Arabi, Ahmad Alaskar
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Abstract Objectives The selected combination was based on limited evidence clinically and in vitro on the efficacy of the Favipiravir and Hydroxychloroquine in SARS-CoV-2. The two medications were listed in many guidelines as treatment options and on
Externí odkaz:
https://doaj.org/article/8f441ec800cb484883e31233e4f0a063
Autor:
Majed Al-Jeraisy, Ahmed Alaskar, Majid Alshamrani, Mohammad Bosaeed, Ahmad Alharbi, Mohammad Hussein, Mohammed Abalkhail, Khizra Sultana, Abrar Musattat, Hajar Alqahtani, Ebrahim Mahmoud, Adel Alothman, Abdulrahman Alsaedy, Omar Aldibasi, Khalid Alhagan, Abdullah Mohammed Asiri, Sameera AlJohani
Publikováno v:
BMJ Open, Vol 11, Iss 4 (2021)
Introduction A novel coronavirus, designated SARS-CoV-2, caused an international outbreak of a respiratory illness, termed COVID-19 in December 2019. There is a lack of specific therapeutic agents based on evidence for this novel coronavirus infectio
Externí odkaz:
https://doaj.org/article/5716984f767441f49fc491a9f6532e6c
Publikováno v:
Case Reports in Infectious Diseases, Vol 2020 (2020)
One of the most effective strategies in reducing the risk of Clostridium difficile infection (CDI) recurrence is fecal microbiota transplantation (FMT). However, several adverse events have been reported post FMT, and data on the efficacy and safety
Externí odkaz:
https://doaj.org/article/eb866b692dd041348ccd3916b751440c